Graduate School of Science, Nagoya University, Nagoya, Aichi, 464-8602, Japan.
Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi, 467-8603, Japan.
Sci Rep. 2017 Oct 23;7(1):13780. doi: 10.1038/s41598-017-13845-8.
Antibody-dependent cellular cytotoxicity (ADCC) is promoted through interaction between the Fc region of immunoglobulin G1 (IgG1) and Fcγ receptor IIIa (FcγRIIIa), depending on N-glycosylation of these glycoproteins. In particular, core fucosylation of IgG1-Fc N-glycans negatively affects this interaction and thereby compromises ADCC activity. To address the mechanisms of this effect, we performed replica-exchange molecular dynamics simulations based on crystallographic analysis of a soluble form of FcγRIIIa (sFcγRIIIa) in complex with IgG1-Fc. Our simulation highlights increased conformational fluctuation of the N-glycan at Asn162 of sFcγRIIIa upon fucosylation of IgG1-Fc, consistent with crystallographic data giving no interpretable electron density for this N-glycan, except for the innermost part. The fucose residue disrupts optimum intermolecular carbohydrate-carbohydrate interactions, rendering this sFcγRIIIa glycan distal from the Fc glycan. Moreover, our simulation demonstrates that core fucosylation of IgG1-Fc affects conformational dynamics and rearrangements of surrounding amino acid residues, typified by Tyr296 of IgG1-Fc, which was more extensively involved in the interaction with sFcγRIIIa without Fc core fucosylation. Our findings offer a structural foundation for designing and developing therapeutic antibodies with improved ADCC activity.
抗体依赖的细胞毒性(ADCC)是通过免疫球蛋白 G1(IgG1)的 Fc 区域与 Fcγ 受体 IIIa(FcγRIIIa)之间的相互作用来促进的,这取决于这些糖蛋白的 N-糖基化。特别是 IgG1-Fc N-糖链的核心岩藻糖基化会负性影响这种相互作用,从而损害 ADCC 活性。为了解决这种影响的机制,我们基于 FcγRIIIa 可溶性形式(sFcγRIIIa)与 IgG1-Fc 复合物的晶体学分析进行了 replica-exchange 分子动力学模拟。我们的模拟强调了 IgG1-Fc 岩藻糖基化后 sFcγRIIIa 中 N-糖链的构象波动增加,这与晶体学数据一致,除了最内部部分外,这些数据没有给出可解释的电子密度。岩藻糖残基破坏了最佳的分子间碳水化合物-碳水化合物相互作用,使 sFcγRIIIa 糖链远离 Fc 糖链。此外,我们的模拟表明,IgG1-Fc 的核心岩藻糖基化会影响构象动力学和周围氨基酸残基的重排,以 IgG1-Fc 的 Tyr296 为代表,在没有 Fc 核心岩藻糖基化的情况下,它更广泛地参与与 sFcγRIIIa 的相互作用。我们的发现为设计和开发具有改善 ADCC 活性的治疗性抗体提供了结构基础。